Log in to your Inderes Free account to see all free content on this page.
Terveystalo
8.6 EUR -1.15%10,945 investors are following this company
Terveystalo operates in the healthcare sector. The company offers services and solutions that, for example, concern surveys and examinations, education and coaching, rehabilitation, and health and fitness mapping. The customers are found among small and medium-sized corporate customers, as well as among actors in the public sector. The head office is located in Helsinki.
P/E (24e)
13.13
EV/EBIT (adj.) (24e)
12.2
P/B (24e)
1.92
Dividend yield-% (24e)
3.72 %
Target price
9.20 EUR
Recommendation
Accumulate
Updated
29.4.2024
NASDAQ Helsinki
TTALO
Daily low / high price
8.59 / 8.73
EUR
Market cap
1.09B EUR
Turnover
126.47K EUR
Volume
15K
Business risk
Valuation risk
Current
Previous
Analyst
![Roni Peuranheimo Roni Peuranheimo](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://core.inderes.fi/sites/default/files/2023-08/Roni_Peuranheimo.jpg)
Roni Peuranheimo
Analyst
Latest videos
Financial calendar
Interim report
17.07.2024
Half year dividend
08.10.2024
Interim report
25.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Varma Mutual Pension Insurance Company | 17.4 % | 17.4 % |
Rettig Group Ab | 16.7 % | 16.7 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Matts Rosenberg | 27.06.2024 | |
Stefan Kullgren | 03.06.2024 | 88,959EUR |
Premium
This content is for our Premium customers only.
Forum updates
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 986.4 | 1,154.6 | 1,259.1 | 1,286.5 | 1,332.1 | 1,369.3 | 1,401.6 | 1,434.6 |
growth-% | -4.3 % | 17.1 % | 9.0 % | 2.2 % | 3.5 % | 2.8 % | 2.4 % | 2.4 % |
EBITDA | 158.0 | 198.1 | 168.9 | 179.1 | 214.9 | 237.7 | 242.9 | 244.8 |
EBIT (adj.) | 93.0 | 128.9 | 88.4 | 104.7 | 132.5 | 149.0 | 153.4 | 155.9 |
EBIT | 67.2 | 110.1 | 33.9 | -14.7 | 110.5 | 134.5 | 141.2 | 144.7 |
Profit before taxes | 56.7 | 100.4 | 31.0 | -38.9 | 82.8 | 108.9 | 119.8 | 128.2 |
Net income | 45.9 | 80.0 | 24.5 | -42.2 | 65.6 | 86.0 | 94.7 | 101.2 |
EPS (adj.) | 0.52 | 0.74 | 0.54 | 0.54 | 0.66 | 0.77 | 0.82 | 0.87 |
growth-% | -11.5 % | 42.9 % | -27.8 % | -0.1 % | 22.3 % | 17.3 % | 7.0 % | 5.5 % |
Dividend | 0.26 | 0.28 | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 |
Dividend ratio | 72.5 % | 44.8 % | 145.1 % | -90.2 % | 62.0 % | 50.2 % | 48.3 % | 47.7 % |
Login required
This content is only available for logged in users
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 16.0 % | 17.2 % | 13.4 % | 13.9 % | 16.1 % | 17.4 % | 17.3 % | 17.1 % |
EBIT-% (adj.) | 9.4 % | 11.2 % | 7.0 % | 8.1 % | 9.9 % | 10.9 % | 10.9 % | 10.9 % |
EBIT-% | 6.8 % | 9.5 % | 2.7 % | -1.1 % | 8.3 % | 9.8 % | 10.1 % | 10.1 % |
ROE | 8.2 % | 13.6 % | 4.1 % | -7.6 % | 12.1 % | 14.6 % | 14.8 % | 14.6 % |
ROI | 5.9 % | 9.6 % | 2.9 % | -1.3 % | 9.7 % | 12.0 % | 12.7 % | 13.1 % |
Login required
This content is only available for logged in users
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 10.04 | 11.84 | 6.25 | 7.74 | 8.60 | 8.60 | 8.60 | 8.60 |
Shares | 128.0 | 128.0 | 127.0 | 127.0 | 127.0 | 127.0 | 127.0 | 127.0 |
Market cap | 1,285.5 | 1,516.0 | 793.8 | 983.3 | 1,092.5 | 1,092.5 | 1,092.5 | 1,092.5 |
Enterprise value | 1,777.1 | 2,035.2 | 1,360.6 | 1,581.3 | 1,616.8 | 1,557.0 | 1,496.0 | 1,434.4 |
EV/S | 1.8 | 1.8 | 1.1 | 1.2 | 1.2 | 1.1 | 1.1 | 1.0 |
EV/EBITDA | 11.2 | 10.3 | 8.1 | 8.8 | 7.5 | 6.6 | 6.2 | 5.9 |
EV/EBIT (adj.) | 19.1 | 15.8 | 15.4 | 15.1 | 12.2 | 10.4 | 9.8 | 9.2 |
EV/EBIT | 26.4 | 18.5 | 40.1 | - | 14.6 | 11.6 | 10.6 | 9.9 |
P/E (adj.) | 19.3 | 15.9 | 11.7 | 14.4 | 13.1 | 11.2 | 10.5 | 9.9 |
P/E | 28.0 | 18.9 | 32.4 | - | 16.6 | 12.7 | 11.5 | 10.8 |
P/B | 2.2 | 2.5 | 1.3 | 1.9 | 1.9 | 1.8 | 1.6 | 1.5 |
P/S | 1.3 | 1.3 | 0.6 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Dividend yield | 2.6 % | 2.4 % | 4.5 % | 3.9 % | 3.7 % | 4.0 % | 4.2 % | 4.4 % |
Equity ratio | 42.0 % | 42.0 % | 40.0 % | 36.3 % | 40.4 % | 43.9 % | 47.7 % | 51.6 % |
Gearing ratio | 85.9 % | 85.3 % | 95.7 % | 116.0 % | 92.2 % | 75.7 % | 60.7 % | 47.4 % |
Login required
This content is only available for logged in users
Quarter data
Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24 | Q2/24e | Q3/24e | Q4/24e | 2024e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 322.4 | 280.5 | 342.5 | 1,286.5 | 350.2 | 331.5 | 292.4 | 358.1 | 1,332.1 |
EBITDA | 43.6 | 36.9 | 52.7 | 179.1 | 61.5 | 47.8 | 43.2 | 62.4 | 214.9 |
EBIT | 14.9 | 10.2 | -58.9 | -14.7 | 35.7 | 21.6 | 17.0 | 36.2 | 110.5 |
Profit before taxes | 9.7 | 3.7 | -66.5 | -38.9 | 29.6 | 14.4 | 9.8 | 29.0 | 82.8 |
Net income | 7.4 | 3.4 | -64.1 | -42.2 | 23.6 | 11.4 | 7.7 | 22.9 | 65.6 |
Login required
This content is only available for logged in users
ShowingAll content types
Terveystalo Oyj: Terveystalo Plc: Flagging announcement in accordance with Chapter 9, Section 10 of the Securities Markets Act
![Terveystalo, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/dac05fc4-1434-455f-b5cb-fa791a58e089.png)
Terveystalo, Q2'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Terveystalo Oyj: Terveystalo Plc: Managers' Transactions, Stefan Kullgren
Terveystalo Oyj: Petra Gräsbeck appointed Terveystalo Plc's SVP, Communications and Public Affairs and member of the Executive Team
![Terveystalo, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/69fec3b3-3838-4e25-ae87-d45da6088c74.png)
Terveystalo, Q1, 2024
Terveystalo Oyj: Terveystalo Group Interim Report January-March 2024: Strong performance driven by improved operational efficiency
Terveystalo Oyj: Terveystalo acquires SRK Group Oy, a provider of imaging services
Terveystalo Oyj: Resolutions of the organising meeting of Terveystalo's Board of Directors
Terveystalo Oyj: Terveystalo Plc: Resolutions of Annual General Meeting
Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Saviharju
Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Mäenalanen
Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Pajunen
Terveystalo Oyj: Terveystalo Plc - Managers' transactions - Iho
Terveystalo Oyj: Notice to the Annual General Meeting of Terveystalo Plc
Terveystalo Oyj: Terveystalo's Annual Report 2023 published
![Terveystalo Q4’23 – Wednesday, Feb. 14 at 11:00 am EET](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/8cc9940a-6956-4f9d-a038-fd7fa31b5122.png)